Braveheart Bio (BRVE) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Braveheart Bio.
Bought (12 mo)
$124,114,950
Sold (12 mo)
$0
Insiders Buying (12 mo)
10
Insiders Selling (12 mo)
0
Form 4 Filings (All Time)
14
Most Recent Purchase
August 11, 2026
Ah Bio Fund IV, L.P.
10%+
$19,800,000
Buys (90d)
0
Sells (90d)
0
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-08-11 | Orbimed Advisors Llc | Director | Buy | $34,920,000 | +1335.0% |
| 2026-08-11 | Ah Bio Fund Iv, L.P. | 10%+ | Buy | $19,800,000 | — |
| 2026-08-11 | Chimovits Erez | Director | Buy | $34,920,000 | +1335.0% |
| 2026-08-10 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10%+ | Other | — | — |
| 2026-08-07 | Murdoch Travis | CEO | Buy | $1,499,994 | +1.0% |
| 2026-08-07 | Forbion Growth Opportunities Fund Iii Cooperatief U.A. | 10%+ | Buy | $64,800,000 | +1879.3% |
| 2026-08-07 | Anderson Michele A. | Officer | Buy | $19,998 | +0.3% |
| 2026-08-07 | Lubner David Charles | Director | Buy | $999,990 | — |
| 2026-08-07 | Chimovits Erez | Director | Award | — | — |
| 2026-08-07 | Bos Jasper | Director | Award | — | — |
| 2026-08-07 | Lohoff Tim | Director | Award | — | — |
| 2026-08-07 | Viehbacher Christopher | Director | Buy | $1,499,994 | +12.3% |
| 2026-08-07 | Rickey James Paul | CFO | Buy | $499,986 | +4.1% |
| 2026-08-07 | Malek David I | Director | Buy | $74,988 | +0.4% |